Abstract
The rapid growth of the HIV/AIDS epidemic in Thailand began in the late 1980s, as in many other countries in Asia, but with a subsequently more rapid upsurge in HIV prevalence than in the other countries. Some factors provided fertile ground for HIV transmission in Thailand, including an extensive sex industry that drew its male clientele from across the socioeconomic spectrum. This coincided with high levels of several other sexually transmissible infections (STI), and the widespread practice of injecting illicit drugs. These risk factors have been exacerbated by a certain societal reticence to publicly acknowledge the ubiquity of sexual and drug use practices that represent potential pathways for HIV transmission.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Behravesh, N. (1993). Measuring the global economic impact of the AIDS epidemic (January 1993), an Insight Report from DRI/McGraw-Hill.
Bryson, Y.J. (1996). Perinatal HIV-1 transmission: Recent advances and therapeutic interventions. AIDS. 10 Suppl. 3: 533–542.
Chamratrithirong, A., Thongthi, V., Boonchalaksi, W., Guest, P., Kanchanachitra, C., and Varangrat, A. (1999). The success of the 100% Condom Promotion Programme in Thailand: survey results of the evaluation of the 100% Condom Promotion Programme. IPSR Publication No. 238. Institute for Population and Social Research, Mahidol University, Bangkok, Thailand.
Chancharoen, K., Kunanusont, C., and Resource Utilization Group of HIV/AIDS in Thailand. (2000). Dollars and sense: cost of medical care. The XIII International Conference on AIDS, Durban, South Africa, July 2000, Session D23. (Unpublished Abstract WeOrD543).
Churdboonchart, V., Moss, R.B., Sirawarapom, W., Smutharaks, B., Sutthent, R., Jensen, F.C., Vacharak, P., Grimes, J., Theofan, G., and Carlo, D.J. (1998). Effect of HIV-Specific Immune-based Therapy in HIV-1 Positive Subjects Infected with HIV-1 Subtype E in Thailand. J. AIDS. 12 (12): 1521–1527.
Churdboonchart, V., Sakondhavat, C., Kulpradist, S., Na Ayudthya, B., Chanderying, V., Rugpao, S., Boonshuyar, C., Sukeepaisarncharoen, W., Sirawaraporn, W., Carlo, D.J., and Moss, R. (2000). A double-blind, adjuvant-controlled trial of human immunodeficiency virus type 1 (HIV-1) immunogen (Remune) monotherapy in asymptomatic, HIV1-infected Thai subjects with CD4-cell counts of >300. Clinical and Diagnostic Laboratory Immunology. 7 (5): 728–733.
Concorde Coordinating Committee. (1994). MRC/ANRS randomized double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Lancet. 343: 871–881.
Connor, E.M., Sperling, R.S., Gelber, R., Kiselev, R, Scott, G., O’Sullivan, M.J., VanDyke, R., Bey, M., Shearer, W., Robert, L., Jimenez, J.E., O’Neil, E., Bazin, B., Delfraissy, J.F., Culnane, M., Coombs, R., Elkins, M., Moye, J., Stratton, R, Balsley, J., for The Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. (1994). Reduction of maternal- infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med. 331: 1173–1180.
Delta Coordinating Committee. (1996). A randomized double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. Lancet. Erratum. 348: 283–291.
Eberstadt, N. (2002). The Future of AIDS. Foreign Affairs. November-December 2002.
Family Health International. (2001). Monitoring the AIDS pandemic: the status and trends of HIV/AIDS/STI epidemics in Asia and the Pacific, MAP Symposium, Melbourne (4 October 2001 ).
Falk, L.A., Goldenthal, K.L., Esparza, J., Aguado, Osmanov, S., Ballou, W.R., Beddows, S., Bhamarapravati, N., Biberfeld, G., Gerrari, G., Hoft, D., Honda, M., Jackson, A., Lu, Y., Marchal, G., McKinney, J. and Yamazaki, S. (2000). Related Articles, Recombinant bacillus Calmette-Guerin as a potential vector for preventive HIV type 1 vaccines. AIDS Res Hum Retroviruses. 16 (2): 91–98.
Fifteenth International AIDS Conference website. (2004). Available at: www.aidsthai.org. Accessed January 30, 2004.
Fischl, M.A., Richman, D.D., Grieco, M.H., Gottlieb, M.S., Volberding, P.A., Laskin, O.L., Leedom, J.M., Groopman, J.E., Mildvan, D., Schooley, R.T., Jackson, G.G., Durack, D.T., Phil, D., King, D., and the AZT Collaborative working group. (1987). The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med. 317:185–191.
Fischi, M.A., Stanley, K., Collier, A.C., Arduino, J.M., Stein, D.S., Feinberg, J.E., Allan J.D., Goldsmith, J.C., and Powderly, W.G., The NIAID AIDS Clinical Trials Group. (1995). Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. Ann Intern Med. 122: 24–32.
Hammer, S.M., Squires, K.E., Hughes, M.D., Grimes, J.M., Demeter, L.M., Currier, J.S., Eron, J.J. J.r., Feinberg, J.E., Balfour, H.H. J.r., Deyton, L.R., Chodakewitz, J.A., and Fischi, M.A., AIDS Clinical Trials Group 320 Study Team. (1997). A controlled trial of two nucleoside analogues plus indinavir in persons with Human Immunodeficiency Virus infection and CD4 cells counts of 200 per cubic millimeter or less. N Engl J Med. 337: 725–733.
Jacqueline, P. (2003). Child Rights and the Media. In: Conference report of IFJ Asia Regional Workshop; June 24–25. Bangkok, Thailand.
Kanshana, S., Thewanda, D., Teeraratkul, A., Limpakarnjanarat, K., Amornwichet, P., Kullerk, N., Akksilp, S., Sereesittipitak, V., Mastro, T.D., and Simonds, R.J. (2000). Implementing short-course zidovudine to reduce mother-infant HIV transmission in a large pilot program in Thailand. AIDS. 14: 1617–1623.
Keiser, P., Nassar, N., Kvanli, M.B., Turner, D., Smith, J.W., and Skiest, D. (2001). Long-term impact of highly active antiretroviral therapy on HIV-related health care costs. Acquirlmmun Defic Syndr. 27: 14–19.
Kunanusont C. (1999). Report of the International Conference on HIV Vaccine Development, Thailand, March 15–19, 1999.
Lallemant, M., Jourdain, G., Le Coeur S., Kim, S., Koetsawang, S., Comeau, A.M., Phoolcharoen, W., Essex, M., McIntosh, K., Ithayasai, V., and the Perinatal HIV Prevention Trial (Thailand) Investigators. (2000). A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. N Engl J Med. 343: 982–991.
Ministry of Public Health, Thailand (1995). Division of Epidemiology. Epidemiological Surveillance Reports.
Ministry of Public Health, Thailand. (2002). National guidelines for the clinical management of HIV infection in children and adults. 7th ed. Bangkok: Ministry of Public Health, pp. 158–163.
Myers, C. and Ashakul, T. (1991). AIDS in Thailand: Some Preliminary Findings. TDRI Quarterly Review. 6 (1): 8–11.
Palella, F.J. J.r., Delaney, K.M., Moorman, A.C., Loveless, M.O., Fuhrer, J., Satten, G.A., Aschman, D.J., and Holmberg, S.D. (1998). Declining morbidity and mortality among patients with advanced Human Immunodeficiency Virus Infection. N Engl J Med. 338: 853–860.
Phanuphak, P., Teeratakulpixarn, S., Sarangbin, S., Nookhai, S., Ubolyam, S., Sirivichayakul, S., Leesavan, A., Forrest, B.D., Hanson, C.V., Li M, Wang, C.Y., and Koff, W.C. (1997). Phase I Trial of an HIV-1 synthetic peptide vaccine in Bangkok, Thailand. Asian Pac JAllergy Immunol. 15: 41–48.
Phoolcharoen, W., Ungchusak, K., Sittritrai, W., and Brown, T. (1998). Thailand: Lessons from a strong national response to HIV/AIDS. AIDS 12 (SupplB): S 123 - S135.
Phoolcharoen, W. (1998). Experience from Thailand, Partners in Prevention: International case studies of effective health promotion practice in HIV/AIDS. UNAIDS Best Practice Collection: Joint United Nations Programme on HIV/AIDS.
Pitayanon, S., Kongsin, S., Janjaroen, W.S. (1997). The Economic Impact of HIV/AIDS Mortality on Households in Thailand. In Bloom, D. and Godwin, P. (eds), The Economics of HIV and AIDS: The Case of South and South-East Asia. Delhi, Oxford University.
Pitisuttithum, P., Phonrat, B., Suntharasamai, P., Raktham, S., Srisuwanvilai, L., Kitayapom, D., Kaewkangwal, J., Migasena, S., Chernow, M., Berman, P., and Francis, D. (2000). Initial Report of a phase VII Safety and Immunogenicity trial of AIDSVAX® B/E rgp120 HIV Vaccine-Bangkok, Thailand. The XII International AIDS Conference. June 9–14. Durban, South Africa. (Unpublished Abstract).
Pitisuttithum, P., and The Bangkok Vaccine Evaluation Group. (2001). Thailand’s Success in Moving to the First Phase III HIV Vaccine Efficacy Trial in a Developing Country (Abstract). AIDS VACCINE 2001, Philadelphia, USA. September 5–8, 2001. p. 144.
Prescott, N., Kunanusont, C., Phoolcharoen, W., Rojanapithayakorn, W., Perriens, J., and Boonyuen, D. (1996). Formulating Rational Use of Antiretrovirals in Thailand. 11th International Conference on AIDS, July 7–121996. Vancouver, Canada. (Unpublished Abstract MoB 533 ).
Rerks-Ngarm, S., Pitisuttithum, P., Kitayaporn, D., Gurunathan, S., Heyward, W., and Brown, A. (2002). Joint Thai-US phase III trial of HIV prime boot vaccines. The XIV International AIDS Conference; (July 7–12, 2002 ); Barcelona, Spain. (Unpublished Abstract).
Rhucharoenpompanich, O., and Chamratrithirong, A. (2001). Demographic impact of AIDS on the Thai population. Asia-Pacific Population Journal. 16 (3): 71–88.
Rumakom, P., Prasartful, P., Guest, P., Thongthai, V., and Punpuing, S. (2002). Change to the epidemiological transition in Thailand due to HIV/AIDS: Implications for population and health policy. Paper presented at the 2002 IUSSP Regional Population Conference, Bangkok, ( June 10–12, 2002 )
Saravolatz, L.D., Winslow, D.L., Collins, G., Hodges, J.S., Pettinelli, C., Stein, D.S., Markowitz, N., Reyes, R., Loveless, M.O., Crane, L., Thompson, M., and Abrams, D. (1996). Zidovudine alone or in combination with didanosine or zalcitabine in HIV-infected patients with the Acquired Immunodeficiency Syndrome or fewer than 200 CD4 cells per cubic millimeter. N Engl J Med. 335: 1099–1106.
Schechter, M. (2002). Universal access to antiretroviral therapy: the Brazilian experience. Powerpoint presentation available at: http://hivinsite.ucsf.edu/InSite.jsp?page=md-rr-06. Accessed January 30, 2004.
Shaffer, N., Chuachoowong, R., Mock, P.A., Bhadrakom, C., Siriwasin, W., Young, N.L., Chotpitayasunondh, T., Chearskul, S., Roongpisuthipong, A., Chinayon, R, Karon, J., Mastro, T.D., Simonds, R.J. and the Bangkok Collaborative Perinatal HIV Transmission Study Group. (1999). Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: A randomised controlled trial. Lancet. 353: 773–780.
Sittitrai, W., Wongsukol, N., Phanuphak, R, and Brown, T. (1992). Female Sexual Behavior: A report on the 1990 Survey of Partner Relations and Risk of HIV Infection in Thailand, Thai Red Cross Society Program on AIDS, Research Report.
The Thai Trial Working Group on HIV/AIDS Projection. (2001). Projections for HIV/AIDS in Thailand: 2000–2020, Kamsana Printing Press, Bangkok.
Thailand Department of Disease Control. (2001). Guidelines for management and monitoring system for provision of HAART in the upper north of Thailand, Disease Control Region 10.
Thailand National AIDS Committee. (1999). Epidemic Status Report.
Thisayakom, U., Ruxrungtham, K., and Phanuphak, P. (1998). Risk reduction of HIV-1 vertical transmission: Progress and implementation in Thailand. HIV & AIDS Current Trends. 4: 1–3.
UNAIDS. (2000). Ethical considerations in HIV-1 pre- ventive vaccine trials. Geneva, Switzerland.
UNAIDS. (2002). Thailand Epidemiological Fact Sheets on HIV/AIDS and Sexually Transmitted Infections, Geneva.
United Nations Children’s Fund (UNICEF) website. (2004). The Mekong Partnership & Beyond. UNICEF and HIV/AIDS in East Asia and the Pacific. Available at:
http://www.unicef.org/eapro-hivaids/home.htm. Accessed: January 30, 2004.
United Nations Population Fund/Country Services Technical Team (UNFPA/CST) Bangkok. (2000). HIV/AIDS and STDs: Causes, Consequences and Preventive Programmes. Occasional Paper Series No. 8. Bangkok, Thailand.
United States Public Health Service. (2000). Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. HIV Clin Trials. 1: 39–64.
Vanhove. G.F., Schapiro, J.M., Winters, M.A., Mcrigan, T.C., and Blaschke, T.F. (1996). Patient compliance and drug failure in protease inhibitor monotherapy. JAMA. 276: 19956.
Vaxgen. (2003). VaxGen Announces Initial Results of its Phase III AIDS Vaccine Trial.Press release available at: http://www.vaxgen.com/pressroom/index.html. Accessed January 30, 2004.
Volberding, P.A., Lagakos, S.W., Koch, M.A., Pettinelli, C., Myers, M.W., Booth, D.K., Balfour, H.H. Jr., Reichman, R.C., Bartlett, J.A., Hirsch, M.S., et al. (1990). Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. N Engl J Med. 322: 941–949.
Volberding, RA., Lagakos, S.W., Koch, M.A., Pettinelli, C., Myers, M.W., Booth, D.K., Balfour, H.H. Jr., Reichman, R.C., Bartlett, J.A., Hirsch, M.S., Murphy, R.L., Hardy, W.D., Wachter, K.W., Knodel, J.E., VanLandingham, M. (2000). AIDS and the Elderly of Thailand: Projecting Familial Impacts. Report No. 00–446. Population Studies Center, Institute for Social Research, University of Michigan.
Wachter, K., Knodel, J., and Vanlandingham, M. (2000). AIDS and the elderly of Thailand: protecting familial impacts. PSC Research Report 00–446, May 2000.
World Health Organization. (2000). The World Health Report 2002: Reducing Risks, Promoting Healthy Life.
Yuntadilok, N. (2002). Keys of effective responses for HIV/AIDS prevention at the border areas (Thai-Myanmar). International AIDS Conference, July 12–14; Barcelona, Spain. Abstract ThPeD7609.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer Science+Business Media New York
About this chapter
Cite this chapter
Phoolcharoen, W., Kunanusont, C., Pitisuttithum, P., Bhamarapravati, N. (2004). HIV/AIDS in Thailand. In: Lu, Y., Essex, M., Stiefvater, E. (eds) AIDS in Asia. Springer, Boston, MA. https://doi.org/10.1007/978-0-306-48536-7_1
Download citation
DOI: https://doi.org/10.1007/978-0-306-48536-7_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-3452-9
Online ISBN: 978-0-306-48536-7
eBook Packages: Springer Book Archive